Allogene Therapeutics Inc (NASDAQ:ALLO)

37.21
Delayed Data
As of Sep 28
 +0.24 / +0.65%
Today’s Change
17.43
Today|||52-Week Range
55.00
+43.23%
Year-to-Date

Today’s Trading

Previous close37.02
Today’s open37.35
Day’s range36.90 - 38.19
Volume521,045
Average volume (3 months)826,676
Market cap$5.2B
Data as of 3:59pm ET, 09/28/2020

Growth & Valuation

Earnings growth (last year)+75.00%
Earnings growth (this year)-18.29%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.31

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.88+1.00%
EBSEmergent BioSolution...-0.01-0.01%
IOVAIovance Biotherapeut...+0.11+0.35%
CRSPCRISPR Therapeutics ...-0.40-0.48%
Data as of 4:24pm ET, 09/28/2020

Financials

Next reporting dateNovember 10, 2020
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$184.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts